Skip to content

“non-inferior to vitamin K antagonists in the treatment of…” — Take Aurally at 40:52

“non-inferior to vitamin K antagonists in the treatment of PE in all the studies and possibly safer in terms of risk of GI and intracranial bleeding as well. The only problem or caveat to that at the moment is that for the DOACs, we don't have any, we have one, but we don't have a lot of available antidotes to those.…”

0:00 1:00:26